SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 71 filers reported holding SIERRA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $341,000 | -80.4% | 258,510 | -74.7% | 0.04% | -81.0% |
| Q3 2018 | $1,739,000 | -45.4% | 1,022,759 | -4.9% | 0.20% | -54.4% |
| Q2 2018 | $3,184,000 | +53.8% | 1,075,806 | +7.6% | 0.44% | +39.8% |
| Q1 2018 | $2,070,000 | +0.9% | 1,000,000 | +81.8% | 0.31% | +30.3% |
| Q4 2017 | $2,052,000 | – | 550,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
| Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
| Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
| Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
| Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
| PA Capital LLC | 138,752 | $183,000 | 0.19% |
| 683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |